Sanofi-Aventis (France) Withdraws Multaq EU Application

September 7, 2006 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

PARIS, Sept 7 (Reuters) - Sanofi-Aventis (SASY.PA: Quote, Profile, Research) has withdrawn its marketing application for its Multaq heart arrhythmia treatment in the European Union, the world's third-largest drugmaker said on Thursday.

>>> Discuss This Story

Twitter
LinkedIn
Facebook
Email
Print

Regulatory Europe

Sanofi (France)